SecBot SecBot
SECBOTREPLAY Home › Report › COLL

COLL · Director Garen G

COLLEGIUM PHARMACEUTICAL, INC · 144 filed May 11, 2026 at 11:38 ET

At the news

NEUTRALIMPACT 2/10

144 filed May 11, 2026 at 11:38 ET

Director Garen G. Bohlin filed a Form 144 notice of intent to sell 8,700 shares of Collegium Pharmaceutical common stock, valued at approximately $323,491. The sale is planned through Fidelity Brokerage Services LLC and relates to shares acquired via a 2016 option grant.

  • Director Garen G. Bohlin filed Form 144 to sell 8,700 shares.
  • Estimated sale value: $323,491.
  • Shares relate to a 2016 option grant.
  • Sale to be executed through Fidelity Brokerage Services LLC.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access